deferoxamine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbeau, A; Poirier, J | 1 |
| Cohen, P; Di Monte, D; Sandy, MS; Smith, MT | 1 |
| Jiang, DH; Lan, J | 1 |
| Ebadi, M; Govitrapong, P; Kooncumchoo, P; Porter, J; Sharma, S | 1 |
| Aguirre, P; Carrasco, CM; Cassels, BK; García-Beltrán, O; González-Billault, C; Mena, NP; Méndez-Gálvez, C; Morales, RA; Muñoz, Y; Núñez, MT; Pérez-Henríquez, P | 1 |
| Codd, R; Double, KL; Finkelstein, DI; Gotsbacher, MP; Telfer, TJ; Witting, PK | 1 |
1 review(s) available for deferoxamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Diseases; Corpus Striatum; Deferoxamine; Dopamine; Female; Glutathione; Glutathione Disulfide; Hydroxyl Radical; Iron; Lipid Peroxides; Male; Mice; Nerve Degeneration; Osmolar Concentration; Vitamin E | 1997 |
5 other study(ies) available for deferoxamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
A catalyst function for MPTP in superoxide formation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Catalysis; Deferoxamine; Free Radicals; Hydrogen-Ion Concentration; Iron; Kinetics; Oxidation-Reduction; Oxygen; Pyridines; Spectrophotometry; Superoxides | 1985 |
Role of active oxygen in paraquat and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) cytotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Carmustine; Cell Survival; Cells, Cultured; Deferoxamine; Free Radicals; Lipid Peroxidation; Liver; Paraquat; Phenylenediamines; Pyridines; Rats; Reference Values; Vitamin E | 1988 |
Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Cell Line; Coenzymes; Deferoxamine; Dopamine; Dopamine Agents; Glutathione; Humans; Iron; Lipid Peroxidation; Melanins; Metallothionein; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Neurons; Neuroprotective Agents; NF-kappa B; Parkinson Disease; Reactive Oxygen Species; Siderophores; Ubiquinone; Vitamins | 2006 |
Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,2'-Dipyridyl; Animals; Antioxidants; Deferiprone; Deferoxamine; Dopaminergic Neurons; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Hydroxyquinolines; Iron Chelating Agents; Lipid Peroxidation; Male; Mesencephalon; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nerve Fibers; Neurites; Neuroprotective Agents; Primary Cell Culture; Pyridones; Rats; Rats, Sprague-Dawley; Synaptophysin; Tyrosine 3-Monooxygenase | 2015 |
Analogues of desferrioxamine B designed to attenuate iron-mediated neurodegeneration: synthesis, characterisation and activity in the MPTP-mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Ascorbic Acid; Benzothiazoles; Blood Proteins; Deferoxamine; Disease Models, Animal; Iron; Iron Chelating Agents; Mice; Nerve Degeneration; Neurons; Parkinson Disease; Sulfonic Acids | 2017 |